Continuous Glucose Monitoring Systems Market by Component (Sensors, Integrated Insulin Pumps, Transmitters & Receivers); by Demographic (Child Population (≤ 14 years), Adult Population (>14 years)); by End User (Diagnostic Centers and Clinics, Home Care, ICU’s); by Region (North America, Europe, Asia-pacific, Latin America, Middle East Africa): Global Forecasts 2021 To 2027

The Global Continuous Glucose Monitoring System Market Size was valued at USD 1.9 Bn in 2020 and is expected to reach USD 8.1 Bn by 2027, with a growing CAGR of 23.2% during the forecast period.

Continuous glucose monitoring system is an FDA approved medical device which is used to track blood sugar levels day and night. It helps to keep continuous check on blood sugar levels. It is fully automated device which display readings within 5-10 minutes. This device helps to analyse data and find ways to manage the sugar condition. This device can be used for both children and adults. Continuous check on glucose level in body helps to monitor daily activities, exercise, and food.

Continuous Glucose Monitoring System Market Size

The driving factors for global continuous glucose monitoring system market include rise in number of diabetic patients, increase in geriatric population and rise in stress level. According to the International Diabetes Federation, 2020, more than 470 million adults are living with diabetes, and it is expected that by 2045 it will rise to 700 million. More than 1.1 million children are living with type-1 diabetes in the world. The statistics anticipate increasing the demand for continuous glucose monitoring system in the market.

Moreover, growth in government initiatives for spreading awareness regarding early diabetes check-ups, growing funds & grants for research and development uplift the growth of continuous glucose monitoring system market. In addition to this, adoption of western lifestyle, increase in consumption of alcohol and smoking and rise in obesity cases triggers the growth of continuous glucose monitoring system market. However, lack of reimbursement policies for devices may hamper the growth of continuous glucose monitoring system market.

Global Continuous Glucose Monitoring System Market Segmentation:

By Components

  • Sensors
  • Integrated Insulin Pumps
  • Transmitters & Receivers

By Demographics

  • Child Population (≤ 14 years)
  • Adult Population (>14 years)

By End User

  • Diagnostic Centers and Clinics
  • Home Care
  • ICU’s

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Based on components, sensors accounted for the largest market share in 2020 and expected to increase more during forecast period due to increase in its application in diagnostics kits

Based on components, continuous glucose monitoring system market is segmented into sensors, integrated insulin pumps and transmitters & receivers. Sensors held the largest market share in 2020 owing to increase in its use in diagnostics, high throughput sensitivity and rising sales of CGMS. These sensors are wireless and placed under the skin or belly or arm, thus provide patient compliance. These parameters fuel the growth of sensor segment in continuous glucose monitoring system market across the globe.

Based on demographics, adult population (>14 years) is expected to exhibit highest market growth during forecast period due to rise in number of adult diabetes patients

Based on demographics, continuous glucose monitoring system market is segmented into adult population (>14 years) and child population (≤ 14 years). Adult population is projected to show highest market growth during forecast period due to rise in incidence of diabetes among adults. Moreover, CGMS provide ease of use to analyse and control diabetes in the adult population. Parameters such as ready-to-go use of CGMS, effective diabetes data management and ease to carry supports the growth of this segment in continuous glucose monitoring system market.

However, child population accounted the highest market growth in 2020 and expected to increase more during forecast period due to increasing number of child diabetic patients across the globe.

Based on end user, diagnostic cneters and clinics accounted for the highest market share in 2020 due to increase in its use of monitoring diabetic patients sugar level

Based on end user, continuous glucose monitoring system market segmented into diagnostics/clinics, home care and ICU’s. Diagnostics/clinics held largest market share in 2020 due to increase in demand for CGMS in diabetes diagnosis. However, home care anticipates highest market growth owing to increase in self-monitoring or self-examine purpose of devices. Covid-19 pandemic boosted the growth of CGMS as people stayed home and diabetic patients monitor their blood sugar level at home. Home care segment is expected to show majority of growth with increase in demand for CGM devices for monitoring glucose level in continuous glucose monitoring systems.

Based on geographical region, North America dominated the continuous glucose monitoring systems market and expected to maintain same dominance during the forecast period owing to increase in diabetic patients and surge in demand for CGMS in this region

Geographically, North America accounted for largest market share in 2020 due to increase in awareness regarding early-diabetes diagnosis and self-diabetes monitoring system. Moreover, increase in geriatric population, increase in incidence of type-1 diabetes and awareness regarding availability of portable diabetic kits drives the growth of continuous glucose monitoring systems market in this region. Further, strong support from government for research, rise in healthcare infrastructure and proper medical device reimbursement policies fuels the growth of this region in continuous glucose monitoring systems market.

However, Asia-Pacific region is expected to witness the fastest market growth with highest CAGR during the forecast period due to significant increase in diabetic patients and rising urbanization in this region boost the growth of continuous glucose monitoring systems market.

Company Profiles and Competitive Intelligence

The key players operating in the continuous glucose monitoring system market are:

  • Abbott laboratories
  • Menarini diagnostics
  • Dexcom, inc.
  • Echo Therapeutics, Inc
  • F. Hoffmann-La Roche ltd.
  • Glysens incorporated
  • Insulet corporation
  • Johnson & Johnson
  • Medtronic plc
  • Senseonics Holdings, inc.
  • Novo Nordisk A/S
  • Ypsomed
  • GlySens, Inc.
  •  Nemaura Medical
  • Tandem Diabetes Care
  • Pfizer Inc.
  • Animas Corporation
  • Baxter International Inc
  • Medtrum Technologies, Inc
  • STMicroelectronics
  • NXP Semiconductors
  •  Qualcomm
  • Taiwan Semiconductor Manufacturing Company Limited
  •   Microchip Technology Inc.
  •  Texas Instruments Inc.
  • Micron Technology Inc.

The report also provides an in-depth analysis of continuous glucose monitoring system market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Increase in incidence of diabetes
  • Rise in geriatric population and life-style diseases
  • Advances in the medical device's technology
  • Growth in government funding and grants for R&D facilities

Restraints

  • Lack of reimbursement policies for devices
  • Lack of data integrity and accuracy
  • Stringent government regulatory guidelines for medical devices and product approvals

Opportunities

  • Exploration of untapped market of developing countries such as India, China and Mexico

Challenges

  • Continuous product launch by competitor companies
  • Rise in number of key market players

COVID-19 Impact on the Continuous Glucose Monitoring System Market Analysis

Covid-19 has highly affected the industries in terms of growth, economy, health and mental wellbeing of every individual. In this challenging situation, every industry is trying to give best services in terms of quality and safety. Sudden outbreak of covid-19 has highlighted the sudden need for the development of innovative patient care solutions to manage hyperglycaemia in hospitalized patients while preserving all resources. There was sudden influx of diabetic patients in the hospitals, as coronavirus was more prevalent to diabetic population.

Due to government restrictions on movement and social distancing, diabetic population required continuous glucose monitoring which shifted their attention towards continuous glucose monitoring systems. This system could provide self-diagnosis and sugar level monitoring at home. This created huge opportunity for the companies for developing more sensitive devices for monitoring blood sugar level.

The report also provides an in-depth analysis of key trends in CGMS market

  • During covid-19, there was sudden increase in CGMS devices, as this device could provide provision of self-examination at home and avid chances of visiting doctor during pandemic. This affected the growth of continuous glucose monitoring systems market across the globe
  • Increase in government spending on medical devices, development in innovative glucose monitoring techniques and rising demand for self-examination drives the growth of continuous glucose monitoring systems market

The report also provides an in-depth analysis of recent news developments and investments

  • In April 2021, Welldoc lauched its first integrated offering for type-2 diabetes named as BlueStar® digital health solution and Dexcom G6 CGM system for healthcare professionals
  • In January 2020, Dexcom entered in partnership with Livongo to expand their portfolio in type-1 diabetes and to manage blood glucose data

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Continuous Glucose Monitoring System Market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global continuous glucose monitoring system market was valued at USD 1.9 Bn in 2020 and is anticipated to reach USD 8.1 Bn by 2027.

The global continuous glucose monitoring system market is estimated to grow at a compound annual growth rate (CAGR) of 23.20 % during the forecast period.

In the base year 2020, North America accounted for 86 % share in the continuous glucose monitoring system market.

Lack of reimbursement policies for devices and lack of data accuracy restraint the growth of global continuous glucose monitoring system market.

As per expert opinions, increase in demand for self-monitored CGM, rise in diabetes population and rise in government spending on healthcare & research facilities will the drive the growth of global continuous glucose monitoring system market.

Few key players include, but not limit up to: Abbott laboratories, Insulet corporation, Menarini diagnostics, Dexcom, inc., F. Hoffmann-La Roche ltd., Glysens incorporated, Echo Therapeutics, Inc, Johnson & Johnson, Medtronic plc, Senseonics Holdings, inc and Novo Nordisk A/S.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Continuous Glucose Monitoring System Market?
    3. Analysis of Continuous Glucose Monitoring System Market
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Continuous Glucose Monitoring System Market
    1. Regulations and Standards
  3. Continuous Glucose Monitoring System Market by Components
    1. Sensors
    2. Integrated Insulin Pumps
    3. Transmitters & Receivers
  4. Continuous Glucose Monitoring System Market by Demographics
    1. Child Population (≤ 14 years)
    2.  Adult Population (>14 years)
  5. Continuous Glucose Monitoring System Market by End User
    1. Diagnostics Centers and Clinics
    2.  Home Care
    3.  ICU’s
  6. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Netherlands
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Latin America
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    5. Middle East Africa (MEA)
      1. South Africa
      2. Rest of MEA
  7. Key Strategic Insights
  8. Market Analysis
    1. New Applications
    2. Emerging Technologies
    3. Opportunity Mapping
    4. Critical Success Factors
    5. Consumer Preferences
  9. Key Market Trends / Recent Developments
  10. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product Launches
    5. Strength of product portfolio
    6. Ranking of Key Players
    7. Presence of players by Geographies
  11. Key global players
    1. Abbott Laboratories
    2. Menarini Diagnostics
    3. Dexcom, Inc.
    4. Echo Therapeutics, Inc
    5. F. Hoffmann-La Roche ltd.
    6. Glysens Incorporated
    7. Insulet Corporation
    8. Johnson & Johnson
    9. Medtronic plc
    10. Senseonics Holdings, inc.
    11. Novo Nordisk A/S
    12. Ypsomed
    13. GlySens, Inc.
    14.  Nemaura Medical
    15. Tandem Diabetes Care

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization